Diseases, Conditions, Syndromes

Reducing risk of renal failure in obese patients

The angiotensin-converting enzyme (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients, according to a study appearing in an upcoming issue of ...

page 11 from 12